drugset / Trial / NCT00043797
Lidorestat (IDD 676) for the Treatment of Diabetic Neuropathy
RandomizedParallel-groupDouble-blindTreatment
Summary
This clinical trial is to determine an effective dosage and to study the safety of an investigational drug -lidorestat (IDD-676)- which is intended to stop or slow the progression of diabetic peripheral neuropathy.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidorestat | Small molecule | — | — |